Skip to main content
. 2011 Dec;261(3):796–804. doi: 10.1148/radiol.11103503

Figure 5:

Figure 5:

Treatment response estimated with DSC perfusion imaging with gadodiamide (left) and ferumoxytol (right). With gadodiamide, the percentage decrease in tumor rCBV after antiangiogenic treatment varies among no preload, single-dose (s.d.) preload, and double-dose (d.d.) preload groups in each individual rat (n = 6). Conversely, with use of ferumoxytol, treatment response is the same regardless of preload dose.